Press Releases July 27, 2026 09:00 AM

The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call

The Oncology Institute schedules Q2 2026 earnings release and conference call for August 6.

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
TOI

The Oncology Institute, Inc. announced it will release its second quarter 2026 financial results on August 6, 2026, followed by a conference call to discuss the results. The company continues its focus on value-based oncology care with a large clinical network and patient base.

The Oncology Institute Announces Second Quarter 2026 Earnings Release Date and Conference Call
TOI
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Q2 2026 earnings release scheduled for August 6, 2026 with an investor conference call.
  • The company provides specialized, value-based oncology care to about 2.1 million patients across five states.
  • Over 400 clinicians and 100 clinic locations emphasize The Oncology Institute's extensive community care network.

CERRITOS, Calif., July 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its second quarter 2026 financial results on Thursday, August 6, 2026, to be followed by a conference call the same day at 5:00 p.m. (Eastern Time).

The conference call can be accessed live over the phone by dialing 1-833-316-1983 or, for international callers, 1-785-838-9310, and referencing Conference ID: TOI. A replay will be available approximately three hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 11162290. The replay will be available until Thursday, August 20, 2026 at 11:59 p.m. (Eastern Time).

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.

About The Oncology Institute

Founded in 2007, The Oncology Institute, Inc. (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 2.1 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 400 employed and network clinicians and over 100 clinics and network locations of care across five states and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Media
The Oncology Institute, Inc.
[email protected]

Investors
ICR Healthcare
[email protected]


Risks

  • Earnings could fall short of market expectations, impacting investor sentiment.
  • Operations across multiple states expose the company to varying healthcare regulations and reimbursement risks.
  • Dependence on clinical trial participation and advanced care delivery models which may face regulatory or reimbursement challenges.

More from Press Releases

United Maritime Announces the Date for the Second Quarter and Six Months Ended June 30, 2026, Financial Results, Conference Call and Webcast Jul 27, 2026 Seanergy Maritime Announces the Date for the Second Quarter and Six Months Ended June 30, 2026, Financial Results, Conference Call, and Webcast Jul 27, 2026 SEGG Media Positions Lottery.com for $396 Billion Global Lottery Market Jul 27, 2026 NewtekOne, Inc. to Report Second Quarter 2026 Results and Host a Conference Call on Thursday, August 6, 2026 Jul 27, 2026 Telos Corporation to Announce Second Quarter 2026 Financial Results on August 10, 2026 Jul 27, 2026